Due to IL-10 being released by MM cells and potentially polarizing TAM towards an M2 subtype, the inhibition of IL-10/IL-10R pathway by using an anti-IL-10R blocking antibody could reprogram TAM to lose the M2 phenotype [26]. The gene discussed is IL10; the disease is Miyoshi myopathy.